Navigation Links
Miraxion in Medical News

Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program

...eader in the research, development and commercialization of novel drugs that address unmet patient needs. Amarin's CNS development pipeline includes miraxion for Huntington's disease, two programs in Parkinson's disease, one in epilepsy and one in memory and cognition. Amarin is initiating a series of cardi...

Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntington's Disease Program

...a review from its large-scale Phase III studies of miraxion to treat Huntington's disease (HD). The FDA indica...seek a collaborative partner with which to advance miraxion in Huntington's disease." Since the most recent update on miraxion to treat HD on August 1, 2007, the Company has con...
Miraxion in Medical Technology

Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease

... either placebo or 2 grams (1 gram twice daily) of miraxion daily for six months. Study data showed no statist... cognition and Total Functional Capacity outcomes. miraxion was found to be safe and well-tolerated by patient...roader HD community." "Despite this setback with miraxion to treat HD, we remain committed to developing Ama...
Miraxion in Biological Technology

Amarin Announces Financial Results for Fourth Quarter and Full Year 2007

...25 per share for the year ended December 31, 2006. The increase in net loss for the year is primarily due to the previously announced write-off of the miraxion intangible asset of $8.8 million in the second quarter of 2007, reorganization costs and higher share-based compensation costs, partly offset by a red...

Amarin Provides Business Update and Announces Implementation of Reverse Stock Split

... comprehensive analysis of the 12-month data from the US Phase III trial of miraxion (AMR101) in Huntington's disease (HD) showing a statistically significant b...Indication Status 2008 Objectives /Candidate Key Programs miraxion Huntington's - Two Phase - Publish disease ...
Other Tags
(Date:7/9/2014)... an innovative tool that captures heretofore hidden ways that ... a protein that makes breast cancer cells more likely ... trigger cancer,s spread in part by blocking two other ... that suggests these two disease processes could have unexpected ... July 10 issue of Nature , points to ...
(Date:7/9/2014)... used in policing injection drug users in Russia ... , A study, conducted by researchers from ... in collaboration with St. Petersburg Pavlov State University, ... on the health outcomes of a cohort of ... , Those who were arrested by police were ...
(Date:7/9/2014)... 2014) Researchers from Montefiore Medical Center ... of Yeshiva University will present new findings at the ... July 17 in Copenhagen, Denmark. Data from the ... transition from cognitive normality to mild cognitive impairment and ... Aging Study , established in 1980 to examine healthy ...
(Date:7/9/2014)... most important organs in the human body. Its job ... this is its synthesis function and that ... is its detoxification function. Lack of exercise and too ... liver. The resulting diseased cells can lead to inflammations, ... According to the German Liver Foundation, over five million ...
(Date:7/9/2014)... City, July 9, 2014 A study published in ... De Koninck and Robert Bonin, two researchers at Universit ... hypersensitivity using a new method that involves rekindling pain ... could lead to novel means to alleviate chronic pain. ... Universit Laval and Institut universitaire en sant mentale de ...
Breaking Medicine News(10 mins):Health News:Protein pushes breast cancer cells to metastasize 2Health News:Protein pushes breast cancer cells to metastasize 3Health News:BU researchers relate arrests with HIV risk environment 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3Health News:Discovery of a new means to erase pain 2
(Date:7/9/2014)... 2014) Emerging fungal pathogens pose a greater ... causing population declines of amphibians, bats, corals, bees ... South Florida published in the prestigious journal ... or immunological resistance to a deadly chytrid fungus ... "Acquired resistance is important because it is the ...
(Date:7/9/2014)... Researchers from The Cancer Genome Atlas (TCGA) Research ... cancer-causing pathway in lung adenocarcinoma, the most common ... changes may expand the number of possible therapeutic ... greater number of patients with treatable mutations because ... already exist. , TCGA is jointly funded and ...
(Date:7/9/2014)... may be able to cope with the rising salinity of ... Arctic today is best known for its tundra and polar ... to 38 million years ago during what is known as ... huge temperate forest with brackish water, home to a variety ... and giant tortoises. Much of what is known about the ...
Breaking Biology News(10 mins):USF study: Amphibians can acquire resistance to deadly fungus 2Study identifies novel genomic changes in the most common type of lung cancer 2Study identifies novel genomic changes in the most common type of lung cancer 3Shark teeth analysis provides detailed new look at Arctic climate change 2Shark teeth analysis provides detailed new look at Arctic climate change 3
Other Contents